Business Context and Reporting Period
Company: NEXTNRG, INC.
Filing Type: Form 8-K (Current Report)
Report Date: January 28, 2026 (Earliest event reported)
Reporting Period: Events occurring on January 28 and January 29, 2026.
Business Context: The Company, an emerging growth company incorporated in Delaware, reported the entry into two material definitive agreements involving the sale of common stock to a single investor.
Key Financial Metrics
This filing reports specific transaction details rather than comprehensive financial statements. Key metrics derived from the reported transactions include:
- Total Capital Raised: $500,000
- Total Shares Issued: 523,060 shares of common stock
- Transaction 1 (Jan 28): 368,421 shares sold for $350,000 ($0.95 per share)
- Transaction 2 (Jan 29): 154,639 shares sold for $150,000 ($0.97 per share)
Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions outside of the specific proceeds from these stock sales.
Material Changes
The primary material change reported is the increase in outstanding common stock and cash proceeds resulting from the two Stock Purchase Agreements (SPAs). There is no prior comparable period data provided in this specific filing to assess year-over-year or quarter-over-quarter changes in operational metrics.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the SPAs contain customary representations, warranties, and covenants. No specific forward-looking guidance, outlook, or strategic commentary regarding future operations is included in the text of this report.
Risks and Contingencies: The filing notes that certain information in the attached exhibits has been excluded as it is treated as private or confidential. No specific risks or contingencies are detailed in the body of this 8-K.
Investor Verification Checklist
- Verify the identity of the "Purchaser" in the attached Exhibits 10.1 and 10.2 to assess potential conflicts of interest or strategic alignment.
- Confirm the total number of authorized and outstanding shares post-transaction to calculate dilution impact.
- Review the full text of the Stock Purchase Agreements (Exhibits 10.1 and 10.2) for any registration rights, anti-dilution provisions, or liquidation preferences not detailed in the summary.
- Check subsequent filings for the use of the $500,000 in proceeds to determine if they address immediate liquidity needs or fund specific growth initiatives.